Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM) / G. Pruneri, K.P.G.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 76:suppl. 4(2016), pp. P2-08-02.1-P2-08-02.1. (38. Annual CTRC-AACR San Antonio Breast Cancer Symposium San Antonio 2015) [10.1158/1538-7445.SABCS15-P2-08-02].